Skip to main content
Clinical Trials/NCT04385004
NCT04385004
Unknown
Not Applicable

Characterization of the Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in the Intensive Care Unit

University Hospital, Strasbourg, France1 site in 1 country320 target enrollmentApril 27, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Respiratory Distress Syndrome
Sponsor
University Hospital, Strasbourg, France
Enrollment
320
Locations
1
Primary Endpoint
Analysis of Clinical, Biological and Histological Pulmonary and Renal Impairment Related to SARS-CoV-2
Last Updated
5 years ago

Overview

Brief Summary

Renal damage in patients hospitalized for ARDS in the ICU can also be related to multiple causes including, but not limited to, the consequences of hemodynamic fluctuations in these patients or the use of nephrotoxic drugs responsible for acute post-ischemic or toxic tubular necrosis. Frequently observed abnormalities of cioagumation may also have a potential impact on renal structures, particularly glomerular capillaries.

The researchers wish to characterize and phenotype the renal impairment of patients hospitalized in intensive care with tables of severe Covid19 infections in ARDS: clinical, biological and histological (by performing post-mortem biopsies).

Translated with www.DeepL.com/Translator (free version)

Registry
clinicaltrials.gov
Start Date
April 27, 2020
End Date
July 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 years of age
  • Diagnosed Covid-19 by RT PCR
  • Hospitalized in intensive care for management of complications related to Covid-19 from March 1, 2020 to April 20, 2020
  • Patient not having expressed his or her opposition, after information, to the re-use of his or her data for the purposes of this research.

Exclusion Criteria

  • Subject who expressed opposition to participating in the study

Outcomes

Primary Outcomes

Analysis of Clinical, Biological and Histological Pulmonary and Renal Impairment Related to SARS-CoV-2

Time Frame: 1 month

Study Sites (1)

Loading locations...

Similar Trials